Compare AHG & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHG | IIPR |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | China | United States |
| Employees | N/A | 23 |
| Industry | Business Services | Real Estate |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2017 | N/A |
| Metric | AHG | IIPR |
|---|---|---|
| Price | $1.46 | $58.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | 12.3K | ★ 213.2K |
| Earning Date | 08-14-2025 | 05-04-2026 |
| Dividend Yield | N/A | ★ 14.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.69 |
| Revenue Next Year | N/A | $3.80 |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $44.58 |
| 52 Week High | $2.50 | $61.40 |
| Indicator | AHG | IIPR |
|---|---|---|
| Relative Strength Index (RSI) | 32.48 | 58.74 |
| Support Level | $1.28 | $53.80 |
| Resistance Level | $1.67 | $59.37 |
| Average True Range (ATR) | 0.14 | 1.29 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 15.98 | 84.76 |
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.